๐ NMPA Approval!
#Bireociclib Tablets (#Xuan Yuening) by #Xuanzhu Biopharmaceutical Co., Ltd. are now approved for HR+/HER2โ advanced or metastatic breast cancer.
๐ง info@dengyuemed.com
#CDK46Inhibitor #HRPositiveBreastCancer #HER2NegativeBreastCancer #NMPAApproval
#HongKongDengYueMedicine
Hashtag
#HRPositiveBreastCancer
Advertisement ยท 728 ร 90
0
0
0
0
#oncology #breastcancer #NHS #capivasertib #Truqap #AstraZeneca #targetedtherapy #AKT #AKTinhibitors #ATKKinases #HRpositivebreastcancer #HER2negativebreastcancer #PIK3CAgene #AKT1gene #PTENgene #NICE #NICEguidance #genetictesting #BreastCancerNow
www.bbc.co.uk/news/article...
2
1
0
0
Excited to have another therapeutic option to treat advanced HR+ breast cancer - Stephanie Graff
@drsgraff.bsky.social
@fda.gov
oncodaily.com/insight/step...
#BreastCancer #Cancer #DatopotumabDeruxtecan #FDA #HRpositiveBreastCancer #OncoDaily #Oncology #Health #TargetedOncology #Medicine
14
1
0
0